Charles Park
Psychiatry · Lone Tree, CONPI 1235214131
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $85,810 of the $89,061 with a category attached, or 96.3%. AbbVie accounts for 98.8% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $34,511 and has fallen 98.3% since, to $578 in 2025. Among psychiatry clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $500.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$88K
- Otsuka America Pharmaceutical, Inc.$270
- Neurocrine Biosciences, Inc.$206
- Indivior Inc.$135
- Braeburn Inc.$100
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$76
- plus $296 from 11 others
What the payments were for
- Speaking & faculty fees$85,81096%
- Travel & lodging$9281%
- Food & beverage$2,3233%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 128 | $87,978 |
| Otsuka America Pharmaceutical, Inc. | 14 | $270 |
| Neurocrine Biosciences, Inc. | 5 | $206 |
| Indivior Inc. | 6 | $135 |
| Braeburn Inc. | 5 | $100 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $76 |
| Sunovion Pharmaceuticals Inc. | 4 | $55 |
| Tris Pharma Inc | 1 | $44 |
| Bausch Health US, LLC | 2 | $36 |
| Alkermes, Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $20 |
| Tempus AI, Inc | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $16 |
| Lundbeck LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$89,061 in reported general payments places this provider in the 95th percentile of 559 psychiatry providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 13 | $19,235 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 30 | $1,303 |
| Bupropion XlBupropion Hcl | 14 | $725 |
| Duloxetine Hcl | 13 | $581 |
| Aripiprazole | 13 | $525 |
| Prazosin Hcl | 30 | $442 |
| Doxepin Hcl | 29 | $398 |
| Sertraline Hcl | 25 | $368 |
| Lamotrigine | 15 | $354 |
| Gabapentin | 12 | $268 |
| Ziprasidone Hcl | 12 | $251 |
| Divalproex Sodium | 11 | $168 |
| Trazodone Hcl | 25 | $166 |
| Alprazolam ErAlprazolam | 12 | $153 |
| Escitalopram Oxalate | 16 | $109 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $270 | $19,23513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 559 psychiatry providers in Colorado.
Other psychiatry in Lone Tree
- Hy Gia ParkLone Tree$11K
- John HardyPueblo$828K
- Larry SandersLittleton$760K
- Jeffrey RichmondDenver$424K
- Jennifer FrenchGlendale$115K
- Cynthia EppersonAurora$64K
- Brian WiseCentennial$44K
- Robert CowanCentennial$29K
- Brenda CzabanDenver$25K
- John DequardoPueblo$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.